Una dosis de ondansetron parece reducir los vómitos en pacientes con gastroenteritis agu- da atendidos en servicios de urgencias
Abstract
Authorsconclusions: ondansetron therapy decreases the risk of persistent vomiting, hospital admissions and the use of intravenous fluid, in children with vomiting due to gastroenteritis. Treatment guidelines should incorporate ondansetron for the therapy of select childrens with gastroenteritis. Reviewerscommentary: despite the fact that ondansetron appears to reduce the vomiting of patients with gastroenteritis, the information provided by this review does not clear up some doubts that question its widespread application in clinical practice. It would be necessary to conduct more studies that include a broader spectrum of patients and evaluating the benefit of treatment on the patient.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.